Abstract
Purpose
Our objective was to identify potentially modifiable risk factors for preeclampsia in a contemporary American teen population.
Methods
We conducted a retrospective cohort analysis of all teenage deliveries (≤18 years old) at one institution over a 4-year-period. All cases of preeclampsia were identified using the National Working Group for Hypertension in Pregnancy diagnostic criteria and compared to normotensive teenage mothers.
Results
Of the 730 included teen deliveries, 65 (8.9 %) women developed preeclampsia and demonstrated a higher prepregnancy body mass index when compared with controls (32.9 ± 8.4 vs. 30.3 ± 6.1 kg/m2, p = 0.002). Maternal obesity (body mass index ≥30 kg/m2, RR 1.6, 95 % CI 1.0–2.8) and gestational weight gain above the Institute of Medicine recommended levels (RR 2.6, 95 % CI 1.5–4.4) were associated with higher risk for development of preeclampsia. When evaluating by severity or onset of disease, excessive weight gain in pregnancy was the strongest risk factor for mild (n = 58) or late onset (n = 54) preeclampsia (RR 2.5, 95 % CI 1.4–3.4).
Conclusions
Maternal obesity and excessive gestational weight gain place the gravid teen at increased risk for preeclampsia. The modifiable nature of these risk factors permits the possibility of intervention and prevention.
Similar content being viewed by others
Introduction
Preeclampsia is a hypertensive disorder unique to pregnancy that occurs in 5–8 % of pregnancies in the United States [1–3]. The disease is classified as mild in 75 % of cases, and 10 % of cases occur before 34 weeks gestation [4]. Women who develop preeclampsia are at increased risk for development of seizures, pulmonary edema, coagulation defects, hepatic and/or renal failure, cerebral hemorrhage, blindness, and death [2, 5–8]. Preeclampsia also causes significant neonatal compromise. Women with preeclampsia are 3–4 times more likely to deliver a small-for-gestational age infant compared to healthy women [9]. Medically indicated preterm birth resulting from fetal or maternal complications is another serious issue [10]. In addition, women experiencing preeclampsia seem to be at an elevated risk for cardiovascular disease later in life [11, 12]. Currently, there are no proven measures to treat preeclampsia other than delivery.
Teenage pregnancy is associated with many adverse maternal and fetal outcomes including preterm birth, low birth weight, gestational diabetes mellitus and preeclampsia [13–15]. Increasing teenage pregnancy rates, adverse consequences associated with childbearing among teens, and morbidities associated with maternal obesity make this an important public health concern. However, data are lacking with respect to the specific maternal characteristics rendering this group as high risk. Consequently, our objective was to identify potentially modifiable risk factors for preeclampsia in a contemporary American teen population.
Materials and methods
We conducted a retrospective cohort analysis of all teenage deliveries at the Washington Hospital Center (Washington, DC) between 2000 and 2004. Approval from our Institutional Review Board was obtained prior to data collection. Inclusion criteria included nulliparity and maternal age of 18 years or less. Exclusion criteria included multiparity, unknown prepregnancy body mass index (BMI), delivery prior to 20 weeks gestation, and maternal age greater than 18 years.
All cases of preeclampsia were identified using the National Working Group on Research on Hypertension during Pregnancy [16]. The groups were further classified into mild or severe preeclampsia and early onset (<34 weeks) or late onset preeclampsia (≥34 weeks).
Demographic data were abstracted from the prenatal and inpatient records. Maternal age, race/ethnicity, height, and prepregnancy weight were self-reported. Maternal BMI was calculated from the patient’s reported height and prepregnancy weight. For analysis, the subjects were categorized into normal, overweight, obese groups as defined by the National Institutes of Health and the World Health Organization as follows: BMI <25.0 kg/m2 was considered to be normal weight, BMI between 25 and 29.9 kg/m2 were considered overweight, and BMI ≥30 kg/m2 were considered obese. The following data collected were also based on maternal self-report: smoking, illicit substance use, and date of last menstrual period. Gestational age was determined from prenatal records. In cases of uncertain last menstrual period, ultrasound determined gestational age was used. We defined sexually transmitted infection as diagnosis of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, or Treponema pallidum during the pregnancy.
With respect to weight gain in pregnancy, the total amount of gain in pregnancy was divided by the gestational age at delivery to obtain the per-week weight gain value. Then, using the 2009 Institute of Medicine (IOM) guidelines, the subjects were categorized based on whether they gained more than or the recommended amount of weight.
Adverse pregnancy outcomes of interest included gestational diabetes (using the Carpenter and Coustan diagnostic criteria) [17], oligohydramnios (amniotic fluid index <5 cm), and placental abruption (based on diagnosis by clinician). Intra and postpartum outcomes of interest included postpartum hemorrhage (based on diagnosis by clinician), clinical chorioamnionitis or endometritis (confirmed by review of inpatient records), non-reassuring fetal status (confirmed by review of inpatient records) and birth weight.
Data were analyzed using IBM SPSS Statistics software (version 19.0, SPSS, Inc., Chicago, IL) and were summarized using basic descriptive statistics. Analysis was performed using Fisher’s exact, student t test. All p values were two-tailed, with p < 0.05 considered statistically significant.
Results
Of the 10,322 deliveries during the study period, 730 (7.1 %) were to nulliparous teenage mothers with ages ranging from 11 to 18 years who met inclusion criteria. Of the 730 included teen deliveries, 65 (8.9 %) women were diagnosed with preeclampsia. There were 654 (90 %) black mothers, 73 (10 %) Hispanic mothers, and only three white mothers in the study population. Five hundred ninety-seven of 730 (82 %) had a BMI >25 kg/m2. Teenage mothers with preeclampsia had a significantly higher BMI (32.9 ± 8.4 vs. 30.3 ± 6.1, p = 0.002) and had higher gestational weight gain (35.3 ± 15.3 vs. 31.1 ± 14.5 pounds, p = 0.03) than those mothers without preeclampsia. All other maternal demographic data were similar among the groups (Table 1).
Adverse maternal–neonatal outcomes are presented in Table 2. Teenage mother with preeclampsia were more likely to have gestational diabetes mellitus and to experience postpartum hemorrhage.
Maternal obesity (BMI ≥30 kg/m2, RR 1.6, 95 % CI 1.0–2.8) and gestational weight gain above the IOM-recommended levels (RR 2.6, 95 % CI 1.5–4.4) were associated with higher risk for development of preeclampsia. When evaluating by severity or onset of disease, weight gain above IOM-recommended levels was associated with the development of mild (n = 58) or late onset (n = 54) preeclampsia (RR 2.5, 95 % CI 1.4–3.4) (Tables 3, 4). No association was noted between gestational weight gain and either severe or early onset preeclampsia.
Discussion
In this study, we sought to identify potentially modifiable risk factors for preeclampsia in a contemporary American teen population. In our predominantly black inner-city teenage cohort, higher prepregnancy BMI, especially obesity, and gestational weight gain above the IOM-recommended levels place the gravid teen at an elevated risk for development of preeclampsia. However, this association was strongest for mild and late onset preeclampsia. There was no association between gestational weight gain above the IOM-recommended levels and severe or early onset preeclampsia.
There has been sparse data to date investigating risk factors for preeclampsia in teenage mothers. Sukalich et al. [18] recently reported adverse pregnancy outcomes in 4,822 adolescent women. 28 % of the women studied had a BMI ≥25. Preeclampsia was more common in teenage mothers with a BMI ≥25 (OR 1.7, 95 % CI 1.4–2.3). The odds of preeclampsia increased in a graded fashion for overweight, obese, and morbidly obese women, respectively (OR 1.6, 1.9, 3.0). Our study is different in that we used a population that was predominantly black. While we found similar results for mild or late onset preeclampsia, there was no association between obesity and severe or early onset preeclampsia. That excessive weight gain in pregnancy and obesity seem to be risk factors for only the mild variant of this disorder provides further evidence that mild and severe preeclampsia may, at least in part, be pathophysiologically different.
Our study has some limitations which merit discussion. This study was retrospective in design and relied on chart review to establish diagnoses. It is possible that some diagnoses were over or under-diagnosed, which has the potential to bias our results. We used multiparity as an exclusion criterion because parity is a risk factor for obesity due to retained pregnancy weight, which was a significant focal point in our analysis plan. In addition, parity may introduce other confounding that we cannot account for. Furthermore, our BMI calculations were based on self-reported prepregnancy weights, which could potentially impact our findings. However, reported weight is frequently underestimated in overweight females [19]. Consequently, the association we report between prepregnancy BMI and subsequent development of preeclampsia is most likely an underestimate of the true risk.
Despite these limitations, we conclude that maternal obesity and higher than IOM-recommended gestational weight gain place the gravid teen at increased risk for preeclampsia. The modifiable nature of these risk factors permits the possibility of intervention and prevention. The absence of obesity’s impact on early onset or severe preeclampsia in our cohort further supports a role for an underlying genetic predisposition in these women. Elucidating the different mechanisms involved in both variants of this disease may allow development of preventive and medical interventions for preeclampsia and its sequelae.
References
Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R (1990) Epidemiology of preeclampsia and eclampsia in the United States, 1979–1986. Am J Obstet Gynecol 163(2):460–465
Maternal mortality–United States, 1982–1996 (1998) MMWR. Morb Mortal Wkly Rep 47(34):705–707
Sibai BM, Gordon T, Thom E et al (1995) Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 172(2 Pt 1):642–648
Sibai BM (2004) Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol 190(6):1520–1526
Benedetti TJ, Kates R, Williams V (1985) Hemodynamic observations in severe preeclampsia complicated by pulmonary edema. Am J Obstet Gynecol 152(3):330–334
Drislane FW, Wang AM (1997) Multifocal cerebral hemorrhage in eclampsia and severe pre-eclampsia. J Neurol 244(3):194–198
Morriss MC, Twickler DM, Hatab MR, Clarke GD, Peshock RM, Cunningham FG (1997) Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe preeclampsia. Obstet Gynecol 89(4):561–568
Cunningham FG, Fernandez CO, Hernandez C (1995) Blindness associated with preeclampsia and eclampsia. Am J Obstet Gynecol 172(4 Pt 1):1291–1298
Xiao R, Sorensen TK, Williams MA, Luthy DA (2003) Influence of pre-eclampsia on fetal growth. J Matern Fetal Neonatal Med 13(3):157–162
Friedman SA, Schiff E, Kao L, Sibai BM (1995) Neonatal outcome after preterm delivery for preeclampsia. Am J Obstet Gynecol 172(6):1785–1788 (discussion 1788–1792)
Smith GC, Pell JP, Walsh D (2001) Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357(9273):2002–2006
Irgens HU, Reisaeter L, Irgens LM, Lie RT (2001) Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323(7323):1213–1217
Haeri S, Guichard I, Baker AM, Saddlemire S, Boggess KA (2009) The effect of teenage maternal obesity on perinatal outcomes. Obstet Gynecol 113(2):300–304
Goldberg RL, Klerman LV (1995) Adolescent pregnancy: another look. N Engl J Med 332:1161–1162
Fraser AM, Brockert JE, Ward RH (1995) Association of young maternal age with adverse reproductive outcomes. N Engl J Med 332:1113–1117
Roberts JM, Pearson G, Cutler J, Lindheimer M (2003) NHLBI Working Group on Research on Hypertension during Pregnancy. Hypertension 41(3):437–445
Carpenter MW, Coustan DR (1982) Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144:768
Sukalich C, Mingione M, Glantz C (2006) Obstetric outcomes in overweight and obese adolescents. Am J Obstet Gynecol 195:851–855
Rowland ML (1990) Self-reported weight and height. Am J Clin Nutr 52:1125–1133
Acknowledgments
The resources of the BHRC research network are gratefully acknowledged.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baker, A.M., Haeri, S. Estimating risk factors for development of preeclampsia in teen mothers. Arch Gynecol Obstet 286, 1093–1096 (2012). https://doi.org/10.1007/s00404-012-2418-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-012-2418-z